Itshak Golan
Founder & Director of D & D Novel Therapeutics Ltd.
Hebrew University
United Kingdom
Biography
Dr. Golan has completed his PhD in Cell Research and Immunology, Tel-Aviv University and postdoctoral studies in Hebrew University Medical School of Jerusalem and B.T.G. Israel Ltd. He was holding, during the years, the following academic and other positions; lecturer in Hebrew University Medical School, Honorary Principal Research Fellow in Imperial College, Honorary Senior Lecturer in College of Medicine, Swansea University, R&D/Innovation Manager in Swansea University, Senior Program Manager in NIHR. Dr. Golan is a founder and director of two British Biotechnology Companies developing new biological drugs for autoimmune inflammatory diseases and cancer and serving as an expert/projects evaluator in EU Commission in Brussels. He was awarded for his professional success by Hebrew University and EU Commission. Dr. Golan has published 15 papers in scientific journals, has 36 patents in the field of rheumatoid arthritis and cancer and has been serving as an editorial board member of MOJ Immunology.
Research Interest
Immunology, Autoimmune Disorders,